Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests a possible link between hair loss and thyroid cancer, but doesn't provide definite proof.

Erlotinib can cause persistent excessive hair growth.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

The British Association of Dermatologists celebrated 100 years by looking back at important research, including work on hair loss, skin condition impact, psoriasis treatment, and skin cancer rates.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Natural products can help overcome cancer drug resistance.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

3D bioprinted lung cancer models in a mouse-like structure offer a better way to study radiation effects without using live animals.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.